• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境富集通过 mirna-132 和 hdac3 信号通路预防 Aβ 寡聚体诱导的突触功能障碍。

Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.

机构信息

Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, United States of America; Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.

Central Laboratory and Department of Neurology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Foshan 528300, Guangdong, China.

出版信息

Neurobiol Dis. 2020 Feb;134:104617. doi: 10.1016/j.nbd.2019.104617. Epub 2019 Oct 24.

DOI:10.1016/j.nbd.2019.104617
PMID:31669733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7243177/
Abstract

As the most common cause of progressive cognitive decline in humans, Alzheimer's disease (AD) has been intensively studied, but the mechanisms underlying its profound synaptic dysfunction remain unclear. Here we confirm that exposing wild-type mice to an enriched environment (EE) facilitates signaling in the hippocampus that promotes long-term potentiation (LTP). Exposing the hippocampus of mice kept in standard housing to soluble Aβ oligomers impairs LTP, but EE can fully prevent this. Mechanistically, the key molecular features of the EE benefit are an upregulation of miRNA-132 and an inhibition of histone deacetylase (HDAC) signaling. Specifically, soluble Aβ oligomers decreased miR-132 expression and increased HDAC3 levels in cultured primary neurons. Further, we provide evidence that HDAC3 is a direct target of miR-132. Overexpressing miR-132 or injecting an HDAC3 inhibitor into mice in standard housing mimics the benefits of EE in enhancing hippocampal LTP and preventing hippocampal impairment by Aβ oligomers in vivo. We conclude that EE enhances hippocampal synaptic plasticity by upregulating miRNA-132 and reducing HDAC3 signaling in a way that counteracts the synaptotoxicity of human Aβ oligomers. Our findings provide a rationale for prolonged exposure to cognitive novelty and/or epigenetic modulation to lessen the progressive effects of Aβ accumulation during human brain aging.

摘要

作为人类认知能力进行性下降的最常见原因,阿尔茨海默病(AD)已被深入研究,但导致其严重突触功能障碍的机制仍不清楚。在这里,我们证实,让野生型小鼠置身于丰富环境(EE)中,可促进海马体中的信号传递,从而增强长时程增强(LTP)。将标准环境中饲养的小鼠的海马体暴露于可溶性 Aβ 寡聚体中会损害 LTP,但 EE 可完全预防这种损害。从机制上讲,EE 带来的关键分子特征是 miRNA-132 的上调和组蛋白去乙酰化酶(HDAC)信号的抑制。具体而言,可溶性 Aβ 寡聚体降低了培养的原代神经元中的 miR-132 表达并增加了 HDAC3 水平。此外,我们提供的证据表明,HDAC3 是 miR-132 的直接靶标。在标准环境中饲养的小鼠中过表达 miR-132 或注射 HDAC3 抑制剂可模拟 EE 的益处,即在增强海马体 LTP 和预防 Aβ 寡聚体体内损伤方面发挥作用。我们得出结论,EE 通过上调 miRNA-132 和降低 HDAC3 信号来增强海马体的突触可塑性,从而抵消了人类 Aβ 寡聚体的突触毒性。我们的发现为长时间接触认知新奇事物和/或表观遗传调节提供了依据,以减轻人类大脑衰老过程中 Aβ 积累的进行性影响。

相似文献

1
Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.环境富集通过 mirna-132 和 hdac3 信号通路预防 Aβ 寡聚体诱导的突触功能障碍。
Neurobiol Dis. 2020 Feb;134:104617. doi: 10.1016/j.nbd.2019.104617. Epub 2019 Oct 24.
2
Environmental novelty activates β2-adrenergic signaling to prevent the impairment of hippocampal LTP by Aβ oligomers.环境新奇性激活β2-肾上腺素能信号传导,防止 Aβ寡聚体对海马长时程增强的损害。
Neuron. 2013 Mar 6;77(5):929-41. doi: 10.1016/j.neuron.2012.12.040.
3
Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.组蛋白去乙酰化酶3的抑制可恢复淀粉样β寡聚体诱导的海马CA1锥体神经元可塑性缺陷。
J Alzheimers Dis. 2016;51(3):783-91. doi: 10.3233/JAD-150838.
4
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.解析具有生物活性的人源 AD 脑可溶性 Aβ 的突触功能障碍,为阿尔茨海默病提供新的治疗途径。
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.
5
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.NR2B 含 NMDA 受体和 mGluR5 代谢型谷氨酸受体在介导 β-淀粉样寡聚体对小鼠海马切片长时程增强(LTP)的突触毒性作用中的治疗意义。
Neuropharmacology. 2011 May;60(6):982-90. doi: 10.1016/j.neuropharm.2011.01.051. Epub 2011 Feb 12.
6
MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.MRZ-99030 - 一种新型的β-淀粉样蛋白聚集调节剂:II - 逆转β-淀粉样蛋白寡聚体诱导的大鼠和小鼠长期增强(LTP)及认知能力缺陷
Neuropharmacology. 2015 May;92:170-82. doi: 10.1016/j.neuropharm.2014.12.037. Epub 2015 Jan 28.
7
miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease.miR-181a 负向调节海马体培养物中的突触可塑性,其抑制可挽救阿尔茨海默病小鼠模型中的记忆缺陷。
Aging Cell. 2020 Mar;19(3):e13118. doi: 10.1111/acel.13118. Epub 2020 Feb 22.
8
Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.可溶性朊蛋白及其N端片段可预防Aβ寡聚体对突触可塑性的损害:对阿尔茨海默病新型治疗策略的启示。
Neurobiol Dis. 2016 Jul;91:124-131. doi: 10.1016/j.nbd.2016.03.001. Epub 2016 Mar 3.
9
WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers.WASP-1是一种典型的Wnt信号增强剂,可挽救由Aβ寡聚体诱导的海马突触损伤。
Exp Neurol. 2015 Feb;264:14-25. doi: 10.1016/j.expneurol.2014.11.005. Epub 2014 Nov 20.
10
Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.β-淀粉样蛋白分泌寡聚体对海马突触可塑性的影响:三聚体的重要作用。
J Physiol. 2006 Apr 15;572(Pt 2):477-92. doi: 10.1113/jphysiol.2005.103754. Epub 2006 Feb 9.

引用本文的文献

1
Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer's disease.对突触体的综合多组学分析揭示了阿尔茨海默病中与突触相关的新靶点。
Mol Psychiatry. 2025 Jun 28. doi: 10.1038/s41380-025-03095-w.
2
Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease.调节神经发生以改善衰老和阿尔茨海默病中的海马可塑性及认知功能
Neurotherapeutics. 2025 Apr;22(3):e00580. doi: 10.1016/j.neurot.2025.e00580. Epub 2025 Apr 2.
3
A bibliometric analysis of studies on environmental enrichment spanning 1967-2024: patterns and trends over the years.

本文引用的文献

1
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.解析具有生物活性的人源 AD 脑可溶性 Aβ 的突触功能障碍,为阿尔茨海默病提供新的治疗途径。
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.
2
Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.抑制 HDAC3 可逆转体外阿尔茨海默病相关病理和 3xTg-AD 小鼠模型中的病理。
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11148-E11157. doi: 10.1073/pnas.1805436115. Epub 2018 Nov 5.
3
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.
1967年至2024年环境富集研究的文献计量分析:历年模式与趋势
Front Behav Neurosci. 2024 Dec 4;18:1501377. doi: 10.3389/fnbeh.2024.1501377. eCollection 2024.
4
The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery.HDAC3的两面性:疾病中的神经炎症与恢复过程中的神经保护作用
Epigenomics. 2024 Nov-Nov;16(21-22):1373-1388. doi: 10.1080/17501911.2024.2419357. Epub 2024 Nov 8.
5
NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer's disease.NACC2,一种位于成人神经发生和阿尔茨海默病之间的 miR-132 调节的分子效应物。
Sci Rep. 2024 Sep 10;14(1):21163. doi: 10.1038/s41598-024-72096-6.
6
Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential.靶向淀粉样β蛋白介导的阿尔茨海默病病理生理过程中的表观遗传机制:揭示治疗潜力。
Neural Regen Res. 2025 Jan 1;20(1):54-66. doi: 10.4103/NRR.NRR-D-23-01827. Epub 2024 Mar 1.
7
The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms.阿尔茨海默病的弹性概念:当前的定义和细胞及分子机制。
Mol Neurodegener. 2024 Apr 8;19(1):33. doi: 10.1186/s13024-024-00719-7.
8
Growth-suppressor microRNAs mediate synaptic overgrowth and behavioral deficits in Fragile X mental retardation protein deficiency.生长抑制性微小RNA介导脆性X智力低下蛋白缺乏时的突触过度生长和行为缺陷。
iScience. 2023 Dec 12;27(1):108676. doi: 10.1016/j.isci.2023.108676. eCollection 2024 Jan 19.
9
miRNA-137-5p improves spatial memory and cognition in Alzheimer's mice by targeting ubiquitin-specific peptidase 30.miRNA-137-5p 通过靶向泛素特异性肽酶 30 改善阿尔茨海默病小鼠的空间记忆和认知能力。
Animal Model Exp Med. 2023 Dec;6(6):526-536. doi: 10.1002/ame2.12368. Epub 2023 Dec 18.
10
Activation of β-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms.β-肾上腺素受体的激活通过表观遗传机制预防 AD 型突触毒性。
Mol Psychiatry. 2023 Nov;28(11):4877-4888. doi: 10.1038/s41380-023-02145-5.
miRNA-132 通过多种信号通路为 tau 病提供神经保护。
Acta Neuropathol. 2018 Oct;136(4):537-555. doi: 10.1007/s00401-018-1880-5. Epub 2018 Jul 7.
4
RNA-Dependent Intergenerational Inheritance of Enhanced Synaptic Plasticity after Environmental Enrichment.环境丰富后增强的突触可塑性的 RNA 依赖性代际遗传。
Cell Rep. 2018 Apr 10;23(2):546-554. doi: 10.1016/j.celrep.2018.03.059.
5
Environmental enrichment, alone or in combination with various pharmacotherapies, confers marked benefits after traumatic brain injury.环境强化,单独或与各种药物治疗联合使用,在创伤性脑损伤后带来显著益处。
Neuropharmacology. 2019 Feb;145(Pt A):13-24. doi: 10.1016/j.neuropharm.2018.02.032. Epub 2018 Feb 27.
6
Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity.环境丰富和运动比社会丰富更能减少淀粉样β神经毒性引起的记忆缺陷。
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2403-E2409. doi: 10.1073/pnas.1718435115. Epub 2018 Feb 20.
7
Deleting HDAC3 rescues long-term memory impairments induced by disruption of the neuron-specific chromatin remodeling subunit BAF53b.删除组蛋白去乙酰化酶3可挽救因神经元特异性染色质重塑亚基BAF53b破坏而导致的长期记忆损伤。
Learn Mem. 2018 Feb 15;25(3):109-114. doi: 10.1101/lm.046920.117. Print 2018 Mar.
8
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.miRTarBase 更新 2018:一个经过实验验证的 microRNA-靶标相互作用的资源库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302. doi: 10.1093/nar/gkx1067.
9
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells.人类神经胶质瘤干细胞释放的细胞外 RNA 的编码和非编码景观。
Nat Commun. 2017 Oct 26;8(1):1145. doi: 10.1038/s41467-017-01196-x.
10
MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.阿尔茨海默病中的 microRNA 再探:对主要神经病理学机制的影响。
Rev Neurosci. 2018 Feb 23;29(2):161-182. doi: 10.1515/revneuro-2017-0042.